BGMS - Bio Green Med Solution, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 5.83 -0.63 (-10.81%) | 0.0 (0.0%) | 0.0 (0.0%) | 0.0 (0.0%) | -0.22 (-3.77%) | -0.57 (-10.12%) | 0.0 (0.0%) | 0.0 (0.0%) |
Bio Green Med Solution Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
AfterHours
Earnings & Ratios
- Basic EPS:
- Diluted EPS:
- Basic P/E:
- Diluted P/E:
- RSI(14) 1m:
- 100.0
- VWAP:
- 5.2
- RVol:
- 0.3334
Events
| Period | Kind | Movement | Occurred At |
|---|---|---|---|
| 1m | Price decrease 1m | 5.2 -0.05 (-1.02%) | Oct 15 14:33 |
| Day | Price decrease day | 5.23 -0.6 (-10.33%) | Oct 15 14:09 |
| 1m | Price decrease 1m | 5.42 -0.07 (-1.28%) | Oct 15 13:32 |
| 1m | Price increase 1m | 5.57 +0.08 (+1.49%) | Oct 15 12:19 |
| 1m | Price increase 1m | 5.58 +0.13 (+2.41%) | Oct 15 11:57 |